Repligen Corporation

RGEN Healthcare Medical Instruments & Supplies

Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.

Revenue
+10.9%
EPS
−351.9%
Free cash flow
−11.5%
Total debt
+3.28%

Quarter to September 2026, against a year earlier

173.01 4.53 +2.69%
Market cap
$10.8B
P/E
0.0×
Fwd P/E
−615×
Dividend yield
—
F-score
6/9
Altman Z
7.49
Beneish M
−2.52
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
89.00 50.77 138.79 205.56 168.10 113.18 48.21 267.52 0.00 188.34
Piotroski F-Score
3 5 5 5 6 5 4 4 4 6
P/S ratio
10.00 10.03 11.90 16.55 27.50 21.73 11.21 15.80 12.69 12.48
Altman Z-Score
6.10 6.02 9.27 8.68 16.90 15.29 10.18 7.83 6.42 7.49
P/FCF ratio
322.68 118.11 115.48 101.49 277.58 305.20 107.29 133.33 83.67 215.98
Altman Z″-Score (non-manufacturers)
4.87 6.00 5.46 6.24 6.67 5.31 5.88 5.19 4.98 5.48
Beneish M-Score
(2.52) (1.25) (2.36) (2.53) (1.96) (1.75) (2.41) (2.42) (2.76) (2.52)
P/Operating CF
535.21 93.11 415.53 253.01 677.22 293.64 145.19 343.71 205.52 358.49
P/B ratio
6.20 2.40 3.75 4.22 6.59 8.33 4.70 5.08 4.08 4.38
EV/Sales
9.56 10.20 11.95 15.43 26.27 21.36 10.95 15.53 12.44 12.27
EV/EBITDA
46.90 58.77 50.38 64.68 89.22 65.94 31.63 82.71 157.32 60.17
EV/FCF
308.33 120.09 115.98 94.66 265.25 300.03 104.81 131.03 81.98 212.32
Current Ratio
8.74 9.63 2.12 13.28 2.83 2.48 2.47 6.74 8.41 8.37
Net Debt/EBITDA
(2.18) (3.04) (1.96) (4.66) (4.15) (1.13) (0.75) (1.45) (4.62) (1.50)
Debt/Equity
0.56 0.17 0.17 0.22 0.18 0.20 0.22 0.30 0.27 0.26
ROE
8.01% 7.46% 2.75% 2.56% 4.63% 7.82% 10.16% 1.84% (1.30%) 2.40%
ROA
5.37% 5.49% 2.19% 1.97% 3.63% 6.02% 7.61% 1.33% (0.90%) 1.69%
ROIC
8.17% 1.69% 3.09% 2.97% 4.03% 6.95% 8.25% 1.66% (1.26%) 1.83%
Return on Tangible Assets
6.56% 11.81% 9.33% 3.34% 9.22% 18.83% 23.70% 3.08% (2.24%) 4.12%
Average Days of Receivables
55.98 71.68 67.26 58.98 71.14 63.92 52.94 71.67 77.16 78.41
Earnings Yield
1.12% 1.97% 0.72% 0.49% 0.59% 0.88% 2.07% 0.37% (0.31%) 0.53%
Free Cash Flow Yield
0.31% 0.85% 0.87% 0.99% 0.36% 0.33% 0.93% 0.75% 1.20% 0.46%
Free Cash Flow per Share
0.10 0.31 0.43 0.91 0.69 0.87 0.70 1.34 2.55 1.63
Book value per Share
5.03 15.47 14.06 21.92 29.10 31.81 34.45 35.26 35.27 37.45
Free Cash Flow
3.24 12.00 18.73 44.06 36.28 47.74 38.74 74.93 142.49 91.93
EV/EBIT
62.56 102.87 89.20 115.60 137.83 85.64 39.06 205.82 0.00 164.20
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026